Switch theme
Sign up to access all valuation multiples
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
1997
20
LTM Revenue n/a
LTM EBITDA n/a
$41.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
European Medical has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, European Medical achieved revenue of $43.6M and an EBITDA of $2.2M.
European Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See European Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $37.9M | $43.6M | XXX | XXX | XXX |
| Gross Profit | n/a | $13.2M | XXX | XXX | XXX |
| Gross Margin | NaN% | 30% | XXX | XXX | XXX |
| EBITDA | -$1.3M | $2.2M | XXX | XXX | XXX |
| EBITDA Margin | -4% | 5% | XXX | XXX | XXX |
| Net Profit | $4.2M | -$6.0M | XXX | XXX | XXX |
| Net Margin | 11% | -14% | XXX | XXX | XXX |
| Net Debt | $2.9M | $6.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, European Medical's stock price is EUR 5 (or $6).
European Medical has current market cap of EUR 23.3M (or $25.0M), and EV of EUR 38.7M (or $41.5M).
See European Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41.5M | $25.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, European Medical has market cap of $25.0M and EV of $41.5M.
European Medical's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate European Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for European Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $41.5M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 19.1x | XXX | XXX | XXX |
| P/E | -32.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -8.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEuropean Medical's NTM/LTM revenue growth is n/a
European Medical's revenue per employee for the last fiscal year averaged $2.2M, while opex per employee averaged $0.7M for the same period.
Over next 12 months, European Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate European Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for European Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -261% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $2.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.7M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 33% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| CSL | XXX | XXX | XXX | XXX | XXX | XXX |
| Imugene | XXX | XXX | XXX | XXX | XXX | XXX |
| Prescient Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| GSK India | XXX | XXX | XXX | XXX | XXX | XXX |
| AstraZeneca India | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
European Medical acquired XXX companies to date.
Last acquisition by European Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . European Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was European Medical founded? | European Medical was founded in 1997. |
| Where is European Medical headquartered? | European Medical is headquartered in Belgium. |
| How many employees does European Medical have? | As of today, European Medical has 20 employees. |
| Is European Medical publicy listed? | Yes, European Medical is a public company listed on BRU. |
| What is the stock symbol of European Medical? | European Medical trades under ALEMS ticker. |
| When did European Medical go public? | European Medical went public in 2016. |
| Who are competitors of European Medical? | Similar companies to European Medical include e.g. CSL, Imugene, Prescient Therapeutics, GSK India. |
| What is the current market cap of European Medical? | European Medical's current market cap is $25.0M |
| What is the current revenue growth of European Medical? | European Medical revenue growth between 2023 and 2024 was 15%. |
| Is European Medical profitable? | Yes, European Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
